Showing results (181-190 of 329) with videos related to
Sort By:
Pageof 33
Bjpsych Open|September 6, 2022
Effects of psilocybin versus escitalopram on rumination and thought suppression in depressionTommaso Barba, Sarah Buehler, Hannes Kettner, et al.Neuroscience Insights|October 10, 2024
Neuroimaging and the Investigation of Drug-Drug Interactions Involving PsychedelicsMatthew B Wall, Rebecca Harding, Natalie Ertl, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 31, 2013
Elevating endogenous GABA levels with GAT-1 blockade modulates evoked but not induced responses in human visual cortexSuresh D Muthukumaraswamy, Jim F M Myers, Sue J Wilson, et al.Annals of the New York Academy of Sciences|July 21, 2025
Perturbing whole-brain models of brain hierarchy: An application for depression following pharmacological treatmentMarcel Socoró-Garrigosa, Yonatan Sanz Perl, Morten L Kringelbach, et al.Psychiatry Research|July 31, 2023
Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysisOtto Simonsson, Per Carlbring, Robin Carhart-Harris, et al.Nuclear Medicine and Biology|May 29, 2002
N1'-fluoroethyl-naltrindole (BU97001) and N1'-fluoroethyl-(14-formylamino)-naltrindole (BU97018) potential delta-opioid receptor PET ligandsRobin J Tyacke, Emma S J Robinson, Rebecca Schnabel, et al.Scientific Reports|May 31, 2018
Psilocybin and MDMA reduce costly punishment in the Ultimatum GameAnthony S Gabay, Robin L Carhart-Harris, Ndaba Mazibuko, et al.CNS Spectrums|January 27, 2009
Cape Town consensus on posttraumatic stress disorderDan J Stein, Marylene Cloitre, Charles B Nemeroff, et al.Brain Research|May 5, 2009
Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding siteAtsuko Kimura, Robin J Tyacke, James J Robinson, et al.Journal of Psychopharmacology (Oxford, England)|April 23, 2021
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?Robin L Carhart-Harris, Anne C Wagner, Manish Agrawal, et al.Pageof 33